好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Assessment of Rapidly Progressive Dementias and Related Neurologic Conditions II

Saturday 04/16/16
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Steven Vernino, MD, PhD, FAAN
Participants should be familiar with the differential diagnosis of RPD and the clinical presentation and evaluation of the more common conditions.
2.00 CME credits
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
03:30 PM - 04:30 PM Autoimmune Encephalopathies
Steven Vernino, MD, PhD, FAAN
04:30 PM - 05:30 PM Conventional Infections Presenting as Rapidly Progressive Dementia
Allen J. Aksamit, Jr., MD, FAAN
Faculty Disclosures
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.